Carolinas Wealth Consulting’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-245
Closed -$11.3K 296
2025
Q1
$11.3K Sell
245
-23
-9% -$961 ﹤0.01% 521
2024
Q4
$10.1K Buy
268
+2
+0.8% +$78 ﹤0.01% 545
2024
Q3
$10.8K Buy
266
+12
+5% +$451 ﹤0.01% 555
2024
Q2
$8.79K Buy
254
+47
+23% +$1.74K ﹤0.01% 577
2024
Q1
$7.78K Buy
207
+10
+5% +$357 ﹤0.01% 595
2023
Q4
$7.07K Hold
197
﹤0.01% 582
2023
Q3
$7.67K Sell
197
-239
-55% -$9.74K ﹤0.01% 553
2023
Q2
$17.8K Buy
436
+2
+0.5% +$83 ﹤0.01% 498
2023
Q1
$18.2K Buy
434
+2
+0.5% +$83 ﹤0.01% 508
2022
Q4
$18.7K Buy
432
+17
+4% +$672 ﹤0.01% 508
2022
Q3
$16K Buy
415
+1
+0.2% +$44 ﹤0.01% 478
2022
Q2
$19K Buy
414
+2
+0.5% +$94 ﹤0.01% 455
2022
Q1
$20K Sell
412
-164
-28% -$6.95K ﹤0.01% 479
2021
Q4
$24K Buy
576
+3
+0.5% +$113 0.01% 456
2021
Q3
$20K Buy
573
+297
+108% +$10.1K ﹤0.01% 469
2021
Q2
$9K Hold
276
﹤0.01% 615
2021
Q1
$9K Hold
276
﹤0.01% 627
2020
Q4
$8K Hold
276
﹤0.01% 597
2020
Q3
$7K Buy
276
+77
+39% +$2.04K ﹤0.01% 527
2020
Q2
$5K Buy
+199
New +$5.28K ﹤0.01% 397

Other funds holding EXC

Carolinas Wealth Consulting's EXC Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Exelon (EXC) in Q2 2025, closing a stake of 245 shares — an estimated $11.3K sold.

Carolinas Wealth Consulting first reported a position in EXC in Q2 2020 and held it in 20 quarters. The position peaked at $24K in Q4 2021. 1,176 funds tracked by Wall St. Rank hold EXC as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Exelon position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 245 Exelon shares in Q2 2025, an estimated $11.3K.
  • Carolinas Wealth Consulting first reported a position in Exelon in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's Exelon position peaked at $24K in Q4 2021.
  • 1,176 funds tracked by Wall St. Rank held Exelon as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.